American Diabetes Association Announces New Research Grant Program in Clinical Care Delivery
March 30, 2011
A major new research initiative was announced today by the American Diabetes Association. The awards are part of a $1.5 million initiative being funded by sanofi-aventis U.S., a leading company in the management of diabetes.
The American Diabetes Association - sanofi-aventis U.S. Research Award in Health Services Research for Clinical Care Delivery in Diabetes is intended to support research studies that examine clinical interventions and programs leading to improvements in care delivery, patient engagement and self-management, and supporting and advancing the role of the health care provider team in ongoing diabetes management. Studies ranging from specific educational and behavioral initiatives for patients, care providers, physicians and clinical care teams to community-based programs will be considered. Studies performed in the primary care setting are encouraged.
“Given that more than 85 percent of patients with diabetes are managed in the primary care setting, this program presents a tremendous opportunity to focus on interventions which address the world’s fasting growing chronic disease,” said Robert Henry, MD, President, Medicine & Science, American Diabetes Association. “We welcome the approach and the support we are able to provide as there are many unanswered questions surrounding the most efficient and innovative approaches to obtain optimal care in the management of the diabetes patient.”
“Diabetes is an epidemic that is placing unprecedented burdens on the U.S. health system,” said Robert Cuddihy, MD, Vice President - Medical Diabetes Head, U.S. Medical Affairs, sanofi-aventis U.S. “The complex challenges of managing this chronic disease warrant new research and understanding of how we can best change the future of diabetes. sanofi-aventis believes that stimulating more research in this area will foster greater solutions to help practitioners and ultimately patients in improving their care.”
Some of the areas for potential study the American Diabetes Association will consider for the research program include:
• Novel programs for care delivery in diabetes, including (but not limited to) patient centered care support, integrated diabetes education, patient empowerment, telemedicine and remote patient support
• Identification and assessment of effective interventions, services and educational programs that complement current treatment recommendation and therapies targeting improvements in glycemic control in patients with type 1 and type 2 diabetes
• Programs for overcoming common barriers to diabetes self-management (such as those that address adherence to medications, lifestyle behavior choices, or use of self-monitoring technology)
• Interventions that are designed to improve patient activation and motivation, or that seek to improve patient provider dynamics, to overcome clinical inertia and attitudes, or to address other barriers that prevent patients and providers from achieving care delivery goals
The American Diabetes Association - sanofi-aventis U.S. Research Award in Health Services Research for Clinical Care Delivery in Diabetes application deadline is July 15, 2011. Recipients will be notified in the fall for funding beginning late November 2011. Each investigator must submit an independent research grant application using the American Diabetes Association online research application forms. The American Diabetes Association’s request for applications (RFA) is available at http://professional.diabetes.org.
The American Diabetes Association is leading the fight to Stop Diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. For the past 75 years, our mission has been to prevent and cure diabetes and to improve the lives of all people affected by diabetes.